How do we know what damage a safe intervention has in the long-term: Considering the risk of extra-corporeal shockwave lithotripsy and the onset of diabetes mellitus
- PMID: 26229327
- PMCID: PMC4518376
How do we know what damage a safe intervention has in the long-term: Considering the risk of extra-corporeal shockwave lithotripsy and the onset of diabetes mellitus
Comment on
- Urol Ann. 7(3):361.
References
-
- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378:31–40. - PubMed
-
- Wendt-Nordahl G, Krombach P, Hannak D, Häcker A, Michel MS, Alken P, et al. Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones. BJU Int. 2007;100:1339–43. - PubMed
-
- Makhlouf AA, Thorner D, Ugarte R, Monga M. Shock wave lithotripsy not associated with development of diabetes mellitus at 6 years of follow-up. Urology. 2009;73:4–8. - PubMed
-
- Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I. Association of metabolic syndrome traits and severity of kidney stones: Results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis. 2013;61:923–9. - PubMed
